Aisen, Yana
Gatt, Moshe E.
Hertz, Rachel
Smeir, Elia
Bar-Tana, Jacob
Article History
Received: 28 August 2020
Accepted: 2 February 2021
First Online: 12 March 2021
Competing interests
: J.B.T. is director in SyndromeX, a company that develops drugs for the Metabolic Syndrome. No competing interests for all the remaining authors.